ARTPred is a research driven biotech company in the field of IVF. ARTPred is dedicated to develop a predictive test (PREDICTIFE) for embryo implantation, ased on urinary and vaginal microbiome profiling. It is the mission of ARTPred to make our unique technology available for all IVF patients worldwide in order to avoid unnecessary treatment burden.